Wealthcare Advisory Partners’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,200
Closed -$14K 1187
2021
Q1
$14K Buy
+1,200
New +$14.5K ﹤0.01% 1340
2020
Q2
Sell
-1,200
Closed -$14K 842
2020
Q1
$14K Hold
1,200
﹤0.01% 826
2019
Q4
$17K Hold
1,200
﹤0.01% 809
2019
Q3
$13K Hold
1,200
﹤0.01% 866
2019
Q2
$17K Hold
1,200
﹤0.01% 762
2019
Q1
$17K Hold
1,200
﹤0.01% 698
2018
Q4
$21K Hold
1,200
﹤0.01% 614
2018
Q3
$18K Hold
1,200
﹤0.01% 709
2018
Q2
$17K Buy
+1,200
New +$18K ﹤0.01% 713

Other funds holding INVA

Wealthcare Advisory Partners's INVA Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Innoviva (INVA) in Q2 2021, closing a stake of 1,200 shares — an estimated $14K sold.

Wealthcare Advisory Partners first reported a position in INVA in Q2 2018 and held it in 9 quarters. The position peaked at $21K in Q4 2018. 185 funds tracked by Wall St. Rank hold INVA as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Innoviva position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 1,200 Innoviva shares in Q2 2021, an estimated $14K.
  • Wealthcare Advisory Partners first reported a position in Innoviva in Q2 2018 and held it in 9 quarters.
  • Wealthcare Advisory Partners's Innoviva position peaked at $21K in Q4 2018.
  • 185 funds tracked by Wall St. Rank held Innoviva as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.